ReviewGlobal health action2026
Fortifying essential medicines supply chains in Sub-Saharan Africa - the curious cases of Kenya and Uganda.
Review in Global health action, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Universal Health Coverage (UHC) is the cornerstone of global health policy. Sustainable Development Goal 3.8 ensures access to safe, effective, quality and affordable medicines and vaccines. Sub-Saharan African (SSA) countries continue to face persistent challenges in achieving and maintaining essential medicines supply. National Medicines Policies (NMPs) that strengthen access to essential medicines are critical for UHC. In this scoping review, we take stock of the literature on essential medicines supply chains in SSA and analyze the unique, related provisions in the Kenyan and Ugandan NMPs, countries whose national essential medicines lists (EMLs) align with the WHO's Model List and have adopted reforms specific to medicines supply chains. Comprehensive hand and electronic searches were conducted on the Kenyan and Ugandan government websites to identify recent national medicines policies and laws. PubMed and Google Scholar searches also retrieved relevant research studies. Our review highlights three key features of Kenya's and Uganda's NMPs: 1) development of evidence-based national EMLs, aligned with the WHO's Model List, to guide essential medicines selection, procurement, and resource allocation; 2) devolution of central government authority for essential medicines to local counties; and 3) support and investment in domestic pharmaceutical manufacturing to minimize reliance on essential medicines imports and increase product availability. We discuss how these distinct policies can serve as models for other resource-constrained countries to build resilient, sustainable supply chains, strengthen access to essential medicines, and move closer to UHC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.